Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · IEX Real-Time Price · USD
3.835
+0.035 (0.92%)
Mar 28, 2024, 12:29 PM EDT - Market open

Eton Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
21.3916.3114.4121.312.0726.74
Cash & Cash Equivalents
21.3916.3114.4121.312.0726.74
Cash Growth
31.17%13.18%-32.35%76.49%-54.87%-
Receivables
3.411.855.470.050.470
Inventory
0.910.560.551.240.380
Other Current Assets
1.131.293.182.122.090.77
Total Current Assets
26.842023.624.715.0127.5
Property, Plant & Equipment
0.150.260.2211.280.77
Goodwill and Intangibles
4.744.753.620.580.730
Other Long-Term Assets
0.010.010.020.040.060.05
Total Long-Term Assets
4.95.033.861.622.060.83
Total Assets
31.7425.0327.4726.3217.0728.33
Accounts Payable
1.851.771.772.340.581.42
Current Debt
5.381.031.420.2800
Other Current Liabilities
9.013.661.371.171.390.6
Total Current Liabilities
16.246.464.563.791.962.02
Long-Term Debt
0.025.495.286.864.560
Total Long-Term Liabilities
0.025.495.286.864.560
Total Liabilities
16.2611.959.8410.666.522.02
Total Debt
5.46.526.77.144.560
Debt Growth
-17.20%-2.55%-6.26%56.66%--
Retained Earnings
-104.07-103.13-94.11-92.16-64.19-45.87
Shareholders' Equity
15.4813.0817.6315.6610.5526.3
Net Cash / Debt
15.999.787.7114.157.5126.74
Net Cash / Debt Growth
63.44%26.84%-45.52%88.53%-71.92%-
Net Cash Per Share
0.620.390.310.670.424.17
Working Capital
10.613.5419.0520.9113.0525.48
Book Value Per Share
0.600.520.700.750.594.10
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).